Research hypotheses only — not a treatment, cure, dose, or medical advice. Real validation requires lab and clinical work.

Neoantigen presentation

Predict peptide–MHC class I presentation with MHCflurry. A low presentation %rank flags a candidate tumor epitope — never a confirmed target on its own.

Candidate targets only. Neoantigen presentation predictions have frequent false positives. A strong-looking %rank marks a peptide for wet-lab validation (immunopeptidomics, T-cell assays), not a presented neoantigen — and nothing here is a treatment claim.

Predict presentation

Enter alleles and candidate peptides, then predict to see ranked presentation.